ArticleAnalytical and bioanalytical chemistry2025
A mitochondrial-targeted fluorescent probe for imaging HOCl in ferroptosis and multiple liver injury models.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fluorescent TAPY-bodipy dyads as tools for imaging fungal mitochondria by confocal microscopy and flow cytometry.Analytical and bioanalytical chemistry · 2026Article
- Advances in endogenous hypochlorous acid-mediated regulation of tumor cell fates.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Ferroptosis exerts a significant influence on the pathogenesis, progression, and therapeutic outcomes of liver diseases. Mitochondria play pivotal roles in liver disease and are also an indispensable hub in the final implementation of ferroptosis. The overabundance of mitochondrial HOCl can result in the permeabilization of mitochondria, which can cause cell death and damage to liver tissue. Herein, we designed a fluorescent probe named PTZ-PY based on thiophenazine for HOCl rapid detection. PTZ-PY exhibits excellent sensitivity and high selectivity to HOCl, and the LOD of HOCl is 13 nM. PTZ-PY is capable of targeting mitochondria and effectively monitors fluctuations in endogenous HOCl concentrations within cellular and zebrafish models, and has been utilized to document the escalation of HOCl levels associated with ferroptosis. As an efficient tool for detecting HOCl, PTZ-PY has demonstrated remarkable potential in exploring functions of HOCl in physiological processes, suggesting that it holds a promising application prospect in related research fields.
Indexed as
Identifiers
40764406What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.